Advertisement

Topics

QIAGEN QIAGEN Company Profile

17:41 EST 11th December 2018 | BioPortfolio


News Articles [178 Associated News Articles listed on BioPortfolio]

Qiagen in den Top 5 im TecDAX - ASCO-Meeting startet heute

Die Aktie von Qiagen hat in den vergangenen Wochen ordentlich Gas gegeben. Im Monatsvergleich ist Qiagen sogar mit einer Performance von 13,8 Prozent der fünfstärkste Wert im TecDAX hinter Pfeiffer....

Qiagen gelingt Zulassung in den USA - Aktie nimmt Kurs auf Jahreshoch

Qiagen hat heute bekannt gegeben, dass die US-amerikanische Gesundheitsbehörde FDA eine erweitere Zulassung für einen Lungenkrebstest von Qiagen erteilt hat. Das Testpaket (therascreen EGFR RGQ PCR....

QIAGEN bringt neuartige RNA-Seq-Bibliotheksvorbereitungslösungen für Next-Generation-Sequencing auf den Markt

QIAseq-Portfolio und Nutzerbasis vergrößern sich signifikant, neue Studien über QIAGEN-Lösungen für NGS werden auf der ASHG Konferenz vorgestellt QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard...

QIAGEN künftig nicht nur im TecDAX, sondern auch im MDAX vertreten

Im Zuge der Neuordnung der deutschen Aktienmarktindizes wird QIAGEN ab dem 24. September 2018 auch im MDAX geführt. QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) gab heute bekannt, das...

QIAGEN und NeuMoDx kündigen strategische Partnerschaft zur Vermarktung der nächsten Generation voll integrierter molekularer Diagnostiktests an

QIAGEN führt zwei "Sample to Insight"-Systeme in Europa und auf anderen Märkten ein; NeuMoDx vermarktet in den USA Erstes Testmenü für Infektionskrankheiten und LDTs QIAGEN N.V. (NYSE: QGEN; Frank...

QIAGEN to Join Germany's MDAX Index in Addition to TecDAX

QIAGEN to join MDAX as of September 24, 2018, due to reorganization of German stock market indices QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today that its global shares wi...

QIAGEN: Neue Bewegungshochs nicht ausgeschlossen

Berlin (www.aktiencheck.de) - QIAGEN-Aktienanalyse von LYNX Broker: Philip Morris von LYNX Broker nimmt in einer aktuellen Aktienanalyse die Aktie des Biotech-Unternehmens QIAGEN N.V. (ISIN: NL0012...

QIAGEN: Bekanntmachung nach Art. 5 Abs. 1 und 6 der Verordnung (EU) 596/2014 und Art. 2 Abs. 1 der Delegierten Verordnung (EU) 2016/1052 / Aktienrückkauf

QIAGEN N.V. gibt bekannt, eine zweite Tranche des per Ad-hoc-Mitteilung vom 31. Januar 2018 angekündigten Aktienrückkaufprogramms zu starten. Beginnend ab dem 5. September 2018 wird QIAGEN bis spä....

Drugs and Medications [0 Results]

None

PubMed Articles [14 Associated PubMed Articles listed on BioPortfolio]

BRCA-analyzer: Automatic workflow for processing NGS reads of BRCA1 and BRCA2 genes.

The use of targeted next-generation sequencing (NGS) provides great new opportunities for molecular and medical genetics. However, in order to take advantage of these opportunities, we need to have re...

Early viral-specific T-cell testing predicts late Cytomegalovirus reactivation following Liver Transplantation.

Although antiviral prophylaxis is effective in preventing early cytomegalovirus (CMV) reactivation following liver transplantation (OLT), it predisposes patients to late CMV after prophylaxis has ceas...

Comparative evaluation of a new magnetic bead-based DNA extraction method from fecal samples for downstream next-generation 16S rRNA gene sequencing.

We are colonized by a vast population of genetically diverse microbes, the majority of which are unculturable bacteria that reside within the gastrointestinal tract. As affordable, advanced next-gener...

Quantiferon-Cytomegalovirus assay: A potentially useful tool in the evaluation of CMV-specific CD8+ T-cell reconstitution in pediatric hematopoietic stem cell transplant patients.

Pediatric HSCT recipients are at high risk for CMV reactivation due to their immature immune system and therapy following transplantation. Reconstitution of CMV-specific T-cell immunity is associated ...

Genetic analysis of 12 X-STRs for forensic purposes in Liaoning Manchu population from China.

X-chromosomal short tandem repeats (X-STRs) have been widely used in forensic practice involving complicated cases of kinship and also play an increasingly important role in population genetics. X-STR...

Clinical Trials [4 Associated Clinical Trials listed on BioPortfolio]

Clinical Evaluation of the APTIMA® HPV Assay and Comparison With the HR HC2® Test Using LBC ThinPrep® Specimens

To assess and compare the performance of the HR HPV HC2® test (Qiagen/Digene) and the APTIMA® HPV Assay (Hologic) using LBC Specimens (ThinPrep® Pap Test) for the detection of HPV infec...

Candidate Gene Screening for Attention Deficit/Hyperactive Disorder (ADHD)

Source: Sample bank of Xijing Hospital and Children's Hospital Affiliated to Soochow University; Sample form: Whole blood; Estimated number of samples: 100 patients with ADHD and age, sex ...

GENESIS: Genetic Biopsy for Prediction of Surveillance Intervals After Endoscopic Resection of Colonic Polyps

Colorectal cancer ist the 2nd most leading cancer among men and women in germany. Screening colonoscopy has the potential to detect premalignant lesions. By endoscopical resection of these...

TB Reduction Through ART and TB Screening Project

Tuberculosis (TB) has overtaken HIV as the leading infectious cause of death worldwide and requires a major policy shift for it to be controlled in line with the WHO Stop-TB goal to "end T...

Companies [12 Associated Companies listed on BioPortfolio]

Plexus Corp.

QIAGEN N.V., a Netherlands holding company, is the leading global provider of sample and assay technologies. Sample technologies are used to isolate and process DNA, RNA and proteins from biological s...

QIAGEN GmbH

QIAGEN N.V., a Netherlands-based holding company, is the leading global provider of Sample to Insight solutions that enable customers to gain valuable molecular insights from samp...

QIAGEN N.V.

QIAGEN N.V., a Netherlands-based holding company, is the leading global provider of Sample to Insight solutions that enable customers to gain valuable molecular insights from samp...

QIAGEN QIAGEN

QIAGEN NV

More Information about "QIAGEN QIAGEN" on BioPortfolio

We have published hundreds of QIAGEN QIAGEN news stories on BioPortfolio along with dozens of QIAGEN QIAGEN Clinical Trials and PubMed Articles about QIAGEN QIAGEN for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of QIAGEN QIAGEN Companies in our database. You can also find out about relevant QIAGEN QIAGEN Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record